4.6 Article

Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion

期刊

JOURNAL OF OVARIAN RESEARCH
卷 3, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1757-2215-3-5

关键词

-

资金

  1. Canadian Cancer Society (National Cancer Institute of Canada) [15303]
  2. Cancer Research Society
  3. NCIC

向作者/读者索取更多资源

Background: Activation of bone morphogenetic protein (BMP) 4 signalling in human ovarian cancer cells induces a number of phenotypic changes in vitro, including altered cell morphology, adhesion, motility and invasion, relative to normal human ovarian surface epithelial cells. From these in vitro analyses, we had hypothesized that active BMP signalling promotes the metastatic potential of ovarian cancer. Methods: To test this directly, we engineered OVCA429 human ovarian cancer cells possessing doxycycline-inducible expression of a constitutively-active mutant BMP receptor, ALK3(QD), and administered these cells to immunocompromised mice. Further characterization was performed in vitro to address the role of activated BMP signalling on the EOC phenotype, with particular emphasis on epithelial-mesenchymal transition (EMT) and cell adhesion. Results: Unexpectedly, doxycycline-induced ALK3(QD) expression in OVCA429 cells reduced tumour implantation on peritoneal surfaces and ascites formation when xenografted into immunocompromised mice by intraperitoneal injection. To determine the potential mechanisms controlling this in vivo observation, we followed with several cell culture experiments. Doxycycline-induced ALK3(QD) expression enhanced the refractile, spindle-shaped morphology of cultured OVCA429 cells eliciting an EMT-like response. Using in vitro wound healing assays, we observed that ALK3(QD)-expressing cells migrated with long, cytoplasmic projections extending into the wound space. The phenotypic alterations of ALK3(QD)-expressing cells correlated with changes in specific gene expression patterns of EMT, including increased Snail and Slug and reduced E-cadherin mRNA expression. In addition, ALK3(QD) signalling reduced beta 1- and beta 3-integrin expression, critical molecules involved in ovarian cancer cell adhesion. The combination of reduced E-cadherin and beta-integrin expression correlates directly with the reduced EOC cell cohesion in spheroids and reduced cell adhesion to the extracellular matrix substrates fibronectin and vitronectin that was observed. Conclusions: We propose that the key steps of ovarian cancer metastasis, specifically cell cohesion of multicellular aggregates in ascites and cell adhesion for reattachment to secondary sites, may be inhibited by overactive BMP signalling, thereby decreasing the ultimate malignant potential of ovarian cancer in this model system.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Hormone Use After Nonserous Epithelial Ovarian Cancer Overall and Disease-Free Survival

Laura Power, Georgia Lefas, Pascal Lambert, Diane Kim, Debra Evaniuk, Robert Lotocki, Erin Dean, Mark W. Nachtigal, Alon D. Altman

OBSTETRICS AND GYNECOLOGY (2016)

Article Genetics & Heredity

The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples

Signe Penner-Goeke, Zelda Lichtensztejn, Megan Neufeld, Jennifer L. Ali, Alon D. Altman, Mark W. Nachtigal, Kirk J. McManus

PLOS GENETICS (2017)

Article Oncology

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Cecile Le Page, Kurosh Rahimi, Martin Kobel, Patricia N. Tonin, Liliane Meunier, Lise Portelance, Monique Bernard, Brad H. Nelson, Marcus Q. Bernardini, John M. S. Bartlett, Dimcho Bachvarov, Walter H. Gotlieb, Blake Gilks, Jessica N. McAlpine, Mark W. Nachtigal, Alain Piche, Peter H. Watson, Barbara Vanderhyden, David G. Huntsman, Diane M. Provencher, Anne-Marie Mes-Masson

BMC CANCER (2018)

Article Oncology

Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells

Jennifer L. Ali, Brittany J. Lagasse, Ainsley J. Minuk, Allison J. Love, Amani I. Moraya, Linda Lam, Gilbert Arthur, Spencer B. Gibson, Ludivine Coudiere Morrison, Tamra E. Werbowetski-Ogilvie, Yangxin Fu, Mark W. Nachtigal

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Oncology

Detecting Chromosome Instability in Cancer: Approaches to Resolve Cell-to-Cell Heterogeneity

Chloe C. Lepage, Claire R. Morden, Michaela C. L. Palmer, Mark W. Nachtigal, Kirk J. McManus

CANCERS (2019)

Article Biochemistry & Molecular Biology

Syntheses of l-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells

Makanjuola Ogunsina, Pranati Samadder, Temilolu Idowu, Mark Nachtigal, Frank Schweizer, Gilbert Arthur

MOLECULES (2020)

Article Chemistry, Analytical

Electrochemical characterization of carboplatin at unmodified platinum electrodes and its application to drug consumption studies in ovarian cancer cells

Huy Tran Le Luu, Mark W. Nachtigal, Sabine Kuss

JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2020)

Article Oncology

Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells

Manisha Bungsy, Michaela Cl Palmer, Lucile M. Jeusset, Nicole M. Neudorf, Zelda Lichtensztejn, Mark W. Nachtigal, Kirk J. McManus

Summary: Despite the lack of understanding regarding the early events driving the development of high-grade serous ovarian cancer (HGSOC), emerging evidence suggests that chromosome instability (CIN) and genomic amplification of the Cyclin E1 gene (CCNE1) may play central roles in the pathogenesis. Furthermore, the heterozygous loss of RBX1 and its correlation with reduced expression in HGSOC cases suggest its potential as a novel CIN gene with pathogenic implications for the disease. Experimental studies have shown that reduced RBX1 expression is associated with increased chromosomal instability and abnormal cell growth, ultimately impacting the development of ovarian cancer.

CANCER LETTERS (2021)

Article Oncology

Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples

Claire R. Morden, Ally C. Farrell, Mirka Sliwowski, Zelda Lichtensztejn, Alon D. Altman, Mark W. Nachtigal, Kirk J. McManus

Summary: This study reveals the prevalence and dynamics of chromosome instability (CIN) in ascites and solid tumors of HGSOC, with CIN occurring in 90.9% of ascites samples and 100% of solid tumors. CIN and aneuploidy tend to increase with disease progression but frequently decrease following chemotherapy in responsive disease. The research also identifies a novel difference in CIN levels between solid tumors and ascites samples from the same individual.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer

Chloe Camille Lepage, Michaela Cora Lynn Palmer, Ally Catherina Farrell, Nicole Marie Neudorf, Zelda Lichtensztejn, Mark William Nachtigal, Kirk James McManus

Summary: This study demonstrates that diminished SKP1 or CUL1 expression in fallopian tube secretory epithelial cell models leads to increased Cyclin E1 levels and changes in CIN-associated phenotypes, suggesting that SKP1 and CUL1 may play a novel role as CIN genes in HGSOC precursor cells, potentially contributing to early events in HGSOC development.

BRITISH JOURNAL OF CANCER (2021)

Review Oncology

Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer

Jerry Vriend, Mark W. Nachtigal

Summary: This study utilized public datasets to identify potential therapeutic targets in high-grade serous ovarian cancer by analyzing genes encoding proteins of the ubiquitin proteasome system. The differential expression of genes encoding ubiquitin ligases, ubiquitin ligase adaptors, and Cullin Ring Ligase (CRL) adaptors suggests their potential as novel therapeutic targets. The findings also indicate the involvement of CRLs in HGSOC and highlight the importance of ubiquitin proteasome pathway components in this type of cancer.

CANCERS (2021)

Review Oncology

The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer

Mark W. Nachtigal, Alon D. Altman, Rajat Arora, Frank Schweizer, Gilbert Arthur

Summary: Disease recurrence and chemotherapy resistance are the major causes of mortality for most epithelial ovarian cancer (EOC) patients. The use of glycosylated antitumor ether lipids (GAELs) as a novel therapeutic platform to treat chemotherapy-resistant EOC shows promising results in killing EOC cells both in vitro and in vivo. This suggests that GAELs could be a potential adjuvant therapy for EOC patients with or without chemotherapy resistance.

CANCERS (2022)

Article Genetics & Heredity

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods study

Selina Casalino, Sharon Bruce, Kim Serfas, Alon D. Altman, Sarah Kean, Pascal Lambert, Kirk J. McManus, Jessica N. Hartley, Mark W. Nachtigal

Summary: Individuals with pathogenic variants in BRCA1 or BRCA2 have an increased risk of developing high-grade serous ovarian cancer. Risk-reducing salpingo-oophorectomy (RRSO) is recommended for these individuals to preventatively remove their ovaries and fallopian tubes. The Hereditary Gynecology Clinic (HGC) in Winnipeg, Canada provides specialized care for BRCA-positive individuals. A study was conducted to explore the decision-making processes and experiences of these individuals at the HGC. The study found that the HGC played a supporting role in decision-making, and a novel framework was proposed to consolidate the various influences and implications of RRSO in the context of the HGC.

JOURNAL OF GENETIC COUNSELING (2023)

Article Oncology

Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019

Kelcey Winchar, Pascal Lambert, Kirk J. McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Decker, Mark W. Nachtigal, Alon D. Altman

Summary: This study aimed to examine the rates and factors influencing the acceptance of genetic referrals and testing for ovarian cancer patients (BRCA1/2). The study analyzed data from 944 patients with high-grade ovarian cancer between 2004-2019 using multiple databases and registries. The study found that the rate of genetic referrals fluctuated over time, but the rate of genetic testing increased. Factors such as age, cancer histology, oral contraceptive use history, and family history of ovarian cancer were found to increase the rates of referral and testing. Increasing the rate of genetic testing will help in clinical management and treatment planning for patients.

CURRENT ONCOLOGY (2022)

Article Obstetrics & Gynecology

Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer

Alon D. Altman, Pascal Lambert, Erin Dean, Christine Robinson, Mark W. Nachtigal, Sarah Kean

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2020)

暂无数据